Notice of Preliminary Results

7 November 2016

UDG Healthcare plc

Notice of Preliminary Results

UDG Healthcare plc ("the Company"), a leading international provider of healthcare services, will issue its preliminary results for the year ended 30 September 2016 at 07:00am (GMT) on Thursday 24 November 2016.

The Company will be hosting an analyst and investor presentation at the London Stock Exchange at 09:00am (GMT) on Thursday 24 November 2016. Analysts and investors wishing to attend are asked to contact Powerscourt on the details below, as all attendees need to be pre-registered. The presentation will also be available via live audio webcast and conference call, the details of which are below.

Audio webcast:

http://edge.media-server.com/m/p/g8vc7tax 

Conference call dial-in details:

For further information, please contact:

About UDG Healthcare plc:

Listed on the London Stock Exchange, UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering clinical, commercial, communication and packaging services to the healthcare industry, employing over 7,000 employees at operations across 20 countries including the US, UK, Ireland and Germany.

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Aquilant Specialist Healthcare Services.

Ashfield Commercial & Medical Services is a global leader in commercialisation services for the pharmaceutical and healthcare industry, operating across two broad areas of activity: commercial and clinical services, and healthcare communications. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance (drug safety), regulatory and event management services to over 300 healthcare companies in 18 countries.

Sharp Packaging Services is a global leader in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

Aquilant Specialist Healthcare Services is a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information, please go to: www.udghealthcare.com